Peroxisome proliferator-activated receptor activation is associated with altered plasma one-carbon metabolites and B-vitamin status in rats

Nutrients

Volumn 8, Issue 1, 2016, Pages

  Lysne, Vegard ^a   Strand, Elin ^a   Svingen, Gard F T ^a,b   Bjørndal, Bodil ^a   Pedersen, Eva R ^a,b   Midttun, O ^c   Olsen, Thomas ^a   Ueland, Per M ^a,b   Berge, Rolf K ^a,b   Nygård, Ottar ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BEVITAL AS   (Norway)

Author keywords

Dimethylglycine; Methylmalonic acid; One carbon metabolism; Peroxisome proliferator activated receptors; Tetradecylthioacetic acid

Indexed keywords

1 METHYLNICOTINAMIDE; BETAINE; CHOLINE; COBALAMIN; CYSTATHIONINE; CYSTEINE; DIMETHYLGLYCINE; FLAVINE MONONUCLEOTIDE; HOMOCYSTEINE; METHIONINE; METHYLMALONIC ACID; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PYRIDOXAL; VITAMIN B COMPLEX; 1-(CARBOXYMETHYLTHIO)TETRADECANE; ANTIOXIDANT; MESSENGER RNA; NICOTINIC ACID DERIVATIVE; NICOTINIC ACID METHYL ESTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SARCOSINE; SULFIDE; TRANSFERASE;

ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; FOLIC ACID BLOOD LEVEL; GENE EXPRESSION; KIDNEY CONCENTRATING CAPACITY; MALE; NONHUMAN; RAT; RNA PURIFICATION; SIGNAL TRANSDUCTION; UPREGULATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; GENETICS; LIPID DIET; LIVER; METABOLISM; RANDOMIZATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CHOLINE; DIET, HIGH-FAT; GENE EXPRESSION; LIVER; MALE; METABOLIC NETWORKS AND PATHWAYS; METHYLMALONIC ACID; NIACINAMIDE; NICOTINIC ACIDS; ONE-CARBON GROUP TRANSFERASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA; PPAR-BETA; PYRIDOXAL; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; SARCOSINE; SULFIDES; VITAMIN B COMPLEX;

EID: 84953897312     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8010026     Document Type: Article

References (69)

1. Refsum, H.; Ueland, P.M.; Nygard, O.; Vollset, S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 1998, 49, 31-62. [CrossRef] [PubMed]
2. Clarke, R.; Halsey, J.; Lewington, S.; Lonn, E.; Armitage, J.; Manson, J.E.; Bonaa, K.H.; Spence, J.D.; Nygard, O.; Jamison, R.; et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch. Intern. Med. 2010, 170, 1622-1631. [PubMed]
3. Joseph, J.; Handy, D.E.; Loscalzo, J. Quo vadis: Whither homocysteine research? Cardiovasc. Toxicol. 2009, 9, 53-63. [CrossRef] [PubMed]
4. Ueland, P.M. Choline and betaine in health and disease. J. Inherit. Metab. Dis. 2011, 34, 3-15. [CrossRef] [PubMed]
5. Schartum-Hansen, H.; Pedersen, E.R.; Svingen, G.F.; Ueland, P.M.; Seifert, R.; Ebbing, M.; Strand, E.; Bleie, O.; Nygard, O. Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. Eur. J. Prev. Cardiol. 2014, 22, 606-614. [CrossRef] [PubMed]
6. Svingen, G.F.; Ueland, P.M.; Pedersen, E.K.; Schartum-Hansen, H.; Seifert, R.; Ebbing, M.; Loland, K.H.; Tell, G.S.; Nygard, O. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2041-2048. [CrossRef] [PubMed]
7. Svingen, G.F.; Schartum-Hansen, H.; Ueland, P.M.; Pedersen, E.R.; Seifert, R.; Ebbing, M.; Bonaa, K.H.; Mellgren, G.; Nilsen, D.W.; Nordrehaug, J.E.; et al. Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. Eur. J. Prev. Cardiol. 2014, 22, 743-752. [CrossRef] [PubMed]
8. Lever, M.; George, P.M.; Elmslie, J.L.; Atkinson, W.; Slow, S.; Molyneux, S.L.; Troughton, R.W.; Richards, A.M.; Frampton, C.M.; Chambers, S.T. Betaine and secondary events in an acute coronary syndrome cohort. PLoS ONE 2012. [CrossRef] [PubMed]
9. Selhub, J. Homocysteine metabolism. Annu. Rev. Nutr. 1999, 19, 217-246. [CrossRef] [PubMed]
10. Finkelstein, J.D.; Harris, B.J.; Kyle, W.E. Methionine metabolism in mammals: Kinetic study of betaine-homocysteine methyltransferase. Arch. Biochem. Biophys. 1972, 153, 320-324. [CrossRef]
11. Porter, D.H.; Cook, R.J.; Wagner, C. Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver. Arch. Biochem. Biophys. 1985, 243, 396-407. [CrossRef]
12. Wang, L.; Chen, L.; Tan, Y.; Wei, J.; Chang, Y.; Jin, T.; Zhu, H. Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein e deficient mice via reducing methylation of peroxisomal proliferator-activated receptor alpha promoter. Lipids Health Dis. 2013, 12, 34. [CrossRef] [PubMed]
13. Sheikh, K.; Camejo, G.; Lanne, B.; Halvarsson, T.; Landergren, M.R.; Oakes, N.D. Beyond lipids, pharmacological pparalpha activation has important effects on amino acid metabolism as studied in the rat. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1157-E1165. [CrossRef] [PubMed]
14. Contreras, A.V.; Torres, N.; Tovar, A.R. Ppar-alpha as a key nutritional and environmental sensor for metabolic adaptation. Adv. Nutr. 2013, 4, 439-452. [CrossRef] [PubMed]
15. Rakhshandehroo, M.; Knoch, B.; Muller, M.; Kersten, S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010. [CrossRef] [PubMed]
16. Chakravarthy, M.V.; Pan, Z.; Zhu, Y.; Tordjman, K.; Schneider, J.G.; Coleman, T.; Turk, J.; Semenkovich, C.F. “New” hepatic fat activates pparalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell. Metab. 2005, 1, 309-322. [CrossRef] [PubMed]
17. Forman, B.M.; Chen, J.; Evans, R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 1997, 94, 4312-4317. [CrossRef] [PubMed] Nutrients 2016, 8, 26 11 of 13
18. Vigerust, N.F.; Cacabelos, D.; Burri, L.; Berge, K.; Wergedahl, H.; Christensen, B.; Portero-Otin, M.; Viste, A.; Pamplona, R.; Berge, R.K.; et al. Fish oil and 3-thia fatty acid have additive effects on lipid metabolism but antagonistic effects on oxidative damage when fed to rats for 50 weeks. J. Nutr. Biochem. 2012, 23, 1384-1393. [CrossRef] [PubMed]
19. Kersten, S.; Mandard, S.; Escher, P.; Gonzalez, F.J.; Tafuri, S.; Desvergne, B.; Wahli, W. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J. 2001, 15, 1971-1978. [CrossRef] [PubMed]
20. Aleman, G.; Ortiz, V.; Contreras, A.V.; Quiroz, G.; Ordaz-Nava, G.; Langley, E.; Torres, N.; Tovar, A.R. Hepatic amino acid-degrading enzyme expression is downregulated by natural and synthetic ligands of pparalpha in rats. J. Nutr. 2013, 143, 1211-1218. [CrossRef] [PubMed]
21. Ntaios, G.; Savopoulos, C.; Chatzopoulos, S.; Mikhailidis, D.; Hatzitolios, A. Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: A systematic review and metaanalysis. Atherosclerosis 2011, 214, 11-19. [CrossRef] [PubMed]
22. Lever, M.; McEntyre, C.J.; George, P.M.; Slow, S.; Chambers, S.T.; Foucher, C. Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adults. J. Clin. Lipidol. 2014, 8, 433-440. [CrossRef] [PubMed]
23. Lever, M.; McEntyre, C.J.; George, P.M.; Slow, S.; Elmslie, J.L.; Lunt, H.; Chambers, S.T.; Parry-Strong, A.; Krebs, J.D. Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovasc. Drugs. Ther. 2014, 28, 459-468. [CrossRef] [PubMed]
24. Chu, R.; Lim, H.; Brumfield, L.; Liu, H.; Herring, C.; Ulintz, P.; Reddy, J.K.; Davison, M. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol. Cell. Biol. 2004, 24, 6288-6297. [CrossRef] [PubMed]
25. Wrzesinski, K.; León, I.R.; Kulej, K.; Sprenger, R.R.; Bjorndal, B.; Christensen, B.J.; Berge, R.K.; Ole, N.J.; Rogowska-Wrzesinska, A. Proteomics identifies molecular networks affected by tetradecylthioacetic acid and fish oil supplemented diets. J. Proteom. 2013, 84, 61-77. [CrossRef] [PubMed]
26. Shin, M.; Ohnishi, M.; Iguchi, S.; Sano, K.; Umezawa, C. Peroxisome-proliferator regulates key enzymes of the tryptophan-nad+ pathway. Toxicol. Appl. Pharmacol. 1999, 158, 71-80. [CrossRef] [PubMed]
27. Christensen, B.J.; Berge, K.; Wergedahl, H.; Bohov, P.; Berge, R.K.; Svendsen, E.; Viste, A. Bioactive fatty acids reduce development of gastric cancer following duodenogastric reflux in rats. Surg. Sci. 2012, 3, 34-42. [CrossRef]
28. Bjorndal, B.; Brattelid, T.; Strand, E.; Vigerust, N.F.; Svingen, G.F.; Svardal, A.; Nygard, O.; Berge, R.K. Fish oil and the pan-ppar agonist tetradecylthioacetic acid affect the amino acid and carnitine metabolism in rats. PLoS ONE 2013. [CrossRef] [PubMed]
29. Ueland, P.M.; Midttun, O.; Windelberg, A.; Svardal, A.; Skalevik, R.; Hustad, S. Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin. Chem. Lab. Med. 2007, 45, 1737-1745. [CrossRef] [PubMed]
30. Midttun, O.; Kvalheim, G.; Ueland, P.M. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using hplc-ms/ms. Anal. Bioanal. Chem. 2013, 405, 2009-2017. [CrossRef] [PubMed]
31. Midttun, O.; Hustad, S.; Ueland, P.M. Quantitative profiling of biomarkers related to b-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 2009, 23, 1371-1379. [CrossRef] [PubMed]
32. Kelleher, B.P.; Broin, S.D. Microbiological assay for vitamin b12 performed in 96-well microtitre plates. J. Clin. Pathol. 1991, 44, 592-595. [CrossRef] [PubMed]
33. Molloy, A.M.; Scott, J.M. Microbiological assay for serum, plasma, and red cell folate using cryopreserved ,microtiter plate method. Methods Enzymol. 1997, 281, 43-53. [PubMed]
34. Lysne, V.; Bjorndal, B.; Vik, R.; Nordrehaug, J.E.; Skorve, J.; Nygard, O.; Berge, R.K. A protein extract from chicken reduces plasma homocysteine in rats. Nutrients 2015, 7, 4498-4511. [CrossRef] [PubMed]
35. Andersen, C.L.; Jensen, J.L.; Orntoft, T.F. Normalization of real-time quantitative reverse transcription-pcr data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004, 64, 5245-5250. [CrossRef] [PubMed] Nutrients 2016, 8, 26 12 of 13
36. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate—A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B-Methodol. 1995, 57, 289-300.
37. Cook, R.J.; Misono, K.S.; Wagner, C. Identification of the covalently bound flavin of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria. J. Biol. Chem. 1984, 259, 12475-12480.
38. Kutzbach, C.; Stokstad, E.L. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by s-adenosylmethionine. Biochim. Biophys. Acta 1971, 250, 459-477. [CrossRef]
39. Leclerc, D.; Wilson, A.; Dumas, R.; Gafuik, C.; Song, D.; Watkins, D.; Heng, H.H.; Rommens, J.M.; Scherer, S.W.; Rosenblatt, D.S.; et al. Cloning and mapping of a cdna for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc. Natl. Acad. Sci. USA 1998, 95, 3059-3064. [CrossRef] [PubMed]
40. Herbert, V.; Larrabee, A.R.; Buchanan, J.M. Studies on identification of a folate compound of human serum. J. Clin. Investig. 1962, 41, 1134-1138. [CrossRef] [PubMed]
41. Ericsson, A.; Turner, N.; Hansson, G.I.; Wallenius, K.; Oakes, N.D. Pharmacological pparalpha activation markedly alters plasma turnover of the amino acids glycine, serine and arginine in the rat. PLoS ONE 2014. [CrossRef] [PubMed]
42. Wang, W.; Wu, Z.; Dai, Z.; Yang, Y.; Wang, J.; Wu, G. Glycine metabolism in animals and humans: Implications for nutrition and health. J. Amino Acids 2013, 45, 463-477. [CrossRef] [PubMed]
43. Van Vlies, N.; Ferdinandusse, S.; Turkenburg, M.; Wanders, R.J.; Vaz, F.M. Ppar alpha-activation results in enhanced carnitine biosynthesis and octn2-mediated hepatic carnitine accumulation. Biochim. Biophys. Acta 2007, 1767, 1134-1142. [CrossRef] [PubMed]
44. Bremer, J. Carnitine-metabolism and functions. Physiol. Rev. 1983, 63, 1420-1480. [PubMed]
45. Penberthy, T.; Kirkland, J. Niacin. In Present Knowledge in Nutrition, 10th ed.; Erdman, J.W., Macdonald, I.A., Zeisel, S.H., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2012; pp. 293-306.
46. Vaz, F.M.; Wanders, R.J. Carnitine biosynthesis in mammals. Biochem. J. 2002, 361, 417-429. [CrossRef] [PubMed]
47. Zhang, J.; Blusztajn, J.K.; Zeisel, S.H. Measurement of the formation of betaine aldehyde and betaine in rat-liver mitochondria by a high-pressure liquid-chromatography radioenzymatic-assay. Biochim. Biophys. Acta 1992, 1117, 333-339. [CrossRef]
48. Shin, M.; Kim, I.; Inoue, Y.; Kimura, S.; Gonzalez, F.J. Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha. Mol. Pharmacol. 2006, 70, 1281-1290. [PubMed]
49. Zhen, Y.; Krausz, K.W.; Chen, C.; Idle, J.R.; Gonzalez, F.J. Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol. Endocrinol. 2007, 21, 2136-2151. [CrossRef] [PubMed]
50. Montanez, J.E.; Peters, J.M.; Correll, J.B.; Gonzalez, F.J.; Patterson, A.D. Metabolomics: An essential tool to understand the function of peroxisome proliferator-activated receptor alpha. Toxicol. Pathol. 2013, 41, 410-418. [CrossRef] [PubMed]
51. Pyper, S.R.; Viswakarma, N.; Yu, S.; Reddy, J.K. Ppar Alpha: Energy combustion, hypolipidemia, inflammation and cancer. Nucl. Recept. Signal. 2010, 8, e002.[CrossRef] [PubMed]
52. Mosharov, E.; Cranford, M.R.; Banerjee, R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000, 39, 13005-13011. [CrossRef] [PubMed]
53. Taysi, S. Oxidant/antioxidant status in liver tissue of vitamin b6 deficient rats. Clin. Nutr. 2005, 24, 385-389. [CrossRef] [PubMed]
54. Paul, L.; Ueland, P.M.; Selhub, J. Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation. Nutr. Rev. 2013, 71, 239-244. [CrossRef] [PubMed]
55. Ueland, P.M.; Ulvik, A.; Rios-Avila, L.; Midttun, O.; Gregory, J.F. Direct and functional biomarkers of vitamin b6 status. Annu. Rev. Nutr. 2015, 35, 33-70. [CrossRef] [PubMed]
56. Dyroy, E.; Yndestad, A.; Ueland, T.; Halvorsen, B.; Damas, J.K.; Aukrust, P.; Berge, R.K. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1364-1369. [CrossRef] [PubMed] Nutrients 2016, 8, 26 13 of 13
57. Syversen, U.; Stunes, A.K.; Gustafsson, B.I.; Obrant, K.J.; Nordsletten, L.; Berge, R.; Thommesen, L.; Reseland, J.E. Different skeletal effects of the peroxisome proliferator activated receptor (ppar)alpha agonist fenofibrate and the ppargamma agonist pioglitazone. BMC Endocr. Disord. 2009, 9, 10. [CrossRef] [PubMed]
58. Di Salvo, M.L.; Contestabile, R.; Safo, M.K. Vitamin b(6) salvage enzymes: Mechanism, structure and regulation. Biochim. Biophys. Acta 2011, 1814, 1597-1608. [CrossRef] [PubMed]
59. Devalia, V.; Hamilton, M.S.; Molloy, A.M.; the British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br. J. Haematol. 2014, 166, 496-513. [CrossRef] [PubMed]
60. Hannibal, L.; DiBello, P.M.; Jacobsen, D.W. Proteomics of vitamin b12 processing. Clin. Chem. Lab. Med. 2013, 51, 477-488. [CrossRef] [PubMed]
61. Kim, J.; Hannibal, L.; Gherasim, C.; Jacobsen, D.W.; Banerjee, R. A human vitamin b12 trafficking protein uses glutathione transferase activity for processing alkylcobalamins. J. Biol. Chem. 2009, 284, 33418-33424. [CrossRef] [PubMed]
62. Joseph, J.; Loscalzo, J. Methoxistasis: Integrating the roles of homocysteine and folic acid in cardiovascular pathobiology. Nutrients 2013, 5, 3235-3256. [CrossRef] [PubMed]
63. Dahlhoff, C.; Desmarchelier, C.; Sailer, M.; Furst, R.W.; Haag, A.; Ulbrich, S.E.; Hummel, B.; Obeid, R.; Geisel, J.; Bader, B.L.; et al. Hepatic methionine homeostasis is conserved in c57bl/6n mice on high-fat diet despite major changes in hepatic one-carbon metabolism. PLoS ONE 2013. [CrossRef]
64. Lima, C.P.; Davis, S.R.; Mackey, A.D.; Scheer, J.B.; Williamson, J.; Gregory, J.F., 3rd. Vitamin b-6 deficiency suppresses the hepatic transsulfuration pathway but increases glutathione concentration in rats fed ain-76a or ain-93g diets. J. Nutr. 2006, 136, 2141-2147. [PubMed]
65. Hannibal, L.; DiBello, P.M.; Yu, M.; Miller, A.; Wang, S.; Willard, B.; Rosenblatt, D.S.; Jacobsen, D.W. The mmachc proteome: Hallmarks of functional cobalamin deficiency in humans. Mol. Genet. Metab. 2011, 103, 226-239. [CrossRef] [PubMed]
66. Kobayashi, R.; Murakami, T.; Obayashi, M.; Nakai, N.; Jaskiewicz, J.; Fujiwara, Y.; Shimomura, Y.; Harris, R.A. Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms. Arch. Biochem. Biophys. 2002, 407, 231-240. [CrossRef]
67. Duval, C.; Muller, M.; Kersten, S. Par alpha and dyslipidemia. Biochim. Biophys. Acta 2007, 1771, 961-971.[CrossRef] [PubMed]
68. Peters, J.M.; Cheung, C.; Gonzalez, F.J. Peroxisome proliferator-activated receptor-alpha and liver cancer: Where do we stand? J. Mol. Med. 2005, 83, 774-785. [CrossRef] [PubMed]
69. Duncan, T.M.; Reed, M.C.; Nijhout, H.F. A population model of folate-mediated one-carbon metabolism. Nutrients 2013, 5, 2457-2474. [CrossRef] [PubMed]